These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10647083)

  • 1. Identification and characterization of a new intermediate in the ribosylative inactivation pathway of rifampin by Mycobacterium smegmatis.
    Imai T; Watanabe K; Mikami Y; Yazawa K; Ando A; Nagata Y; Morisaki N; Hashimoto Y; Furihata K; Dabbs ER
    Microb Drug Resist; 1999; 5(4):259-64. PubMed ID: 10647083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADP-ribosylation as an intermediate step in inactivation of rifampin by a mycobacterial gene.
    Quan S; Imai T; Mikami Y; Yazawa K; Dabbs ER; Morisaki N; Iwasaki S; Hashimoto Y; Furihata K
    Antimicrob Agents Chemother; 1999 Jan; 43(1):181-4. PubMed ID: 9869590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures of ADP-ribosylated rifampicin and its metabolite: intermediates of rifampicin-ribosylation by Mycobacterium smegmatis DSM43756.
    Morisaki N; Hashimoto Y; Furihata K; Imai T; Watanabe K; Mikami Y; Yazawa K; Ando A; Nagata Y; Dabbs ER
    J Antibiot (Tokyo); 2000 Mar; 53(3):269-75. PubMed ID: 10819298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light inhibits rifampicin inactivation and reduces rifampicin resistance due to a cloned mycobacterial ADP-ribosylation gene.
    Dabbs ER; Quan S
    FEMS Microbiol Lett; 2000 Jan; 182(1):105-9. PubMed ID: 10612740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure determination of ribosylated rifampicin and its derivative: new inactivated metabolites of rifampicin by mycobacterial strains.
    Morisaki N; Kobayashi H; Iwasaki S; Furihata K; Dabbs ER; Yazawa K; Mikami Y
    J Antibiot (Tokyo); 1995 Nov; 48(11):1299-303. PubMed ID: 8557572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.
    Piddock LJ; Williams KJ; Ricci V
    J Antimicrob Chemother; 2000 Feb; 45(2):159-65. PubMed ID: 10660497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic.
    Quan S; Venter H; Dabbs ER
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2456-60. PubMed ID: 9371349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New C25 carbamate rifamycin derivatives are resistant to inactivation by ADP-ribosyl transferases.
    Combrink KD; Denton DA; Harran S; Ma Z; Chapo K; Yan D; Bonventre E; Roche ED; Doyle TB; Robertson GT; Lynch AS
    Bioorg Med Chem Lett; 2007 Jan; 17(2):522-6. PubMed ID: 17070048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species-Specific Interactions of Arr with RplK Mediate Stringent Response in Bacteria.
    Agrawal P; Varada R; Sah S; Bhattacharyya S; Varshney U
    J Bacteriol; 2018 Mar; 200(6):. PubMed ID: 29311276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Mycobacterium smegmatis deficient in ADP-ribosyltransferase as surrogate for Mycobacterium tuberculosis in drug testing and mutation analysis.
    Agrawal P; Miryala S; Varshney U
    PLoS One; 2015; 10(4):e0122076. PubMed ID: 25874691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The K+ uptake regulator TrkA controls membrane potential, pH homeostasis and multidrug susceptibility in Mycobacterium smegmatis.
    Castañeda-García A; Do TT; Blázquez J
    J Antimicrob Chemother; 2011 Jul; 66(7):1489-98. PubMed ID: 21613307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation.
    Dabbs ER; Yazawa K; Mikami Y; Miyaji M; Morisaki N; Iwasaki S; Furihata K
    Antimicrob Agents Chemother; 1995 Apr; 39(4):1007-9. PubMed ID: 7785970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A temporal proteome dynamics study reveals the molecular basis of induced phenotypic resistance in Mycobacterium smegmatis at sub-lethal rifampicin concentrations.
    Giddey AD; de Kock E; Nakedi KC; Garnett S; Nel AJ; Soares NC; Blackburn JM
    Sci Rep; 2017 Mar; 7():43858. PubMed ID: 28262820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampin- or Capreomycin-Induced Remodeling of the
    Man DK; Kanno T; Manzo G; Robertson BD; Lam JKW; Mason AJ
    mSphere; 2018 Jul; 3(4):. PubMed ID: 30021876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of N-acetylglucosamine-1-phosphate transferase (WecA) enhanced the sensitivity of Mycobacterium smegmatis against rifampin.
    Xu L; Qian L; Kang J; Sha S; Xin Y; Lu S; Ma Y
    J Appl Microbiol; 2016 Oct; 121(4):966-72. PubMed ID: 27420559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr.
    Baysarowich J; Koteva K; Hughes DW; Ejim L; Griffiths E; Zhang K; Junop M; Wright GD
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4886-91. PubMed ID: 18349144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integron-mediated rifampin resistance in Pseudomonas aeruginosa.
    Tribuddharat C; Fennewald M
    Antimicrob Agents Chemother; 1999 Apr; 43(4):960-2. PubMed ID: 10103210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kanglemycin A Can Overcome Rifamycin Resistance Caused by ADP-Ribosylation by Arr Protein.
    Harbottle J; Mosaei H; Allenby N; Zenkin N
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0086421. PubMed ID: 34606341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment and drug susceptibility test of isoniazid resistant Mycobacterium smegmatis].
    Jia PP; Zhao LL; Li XY; Zhang Q; Liu ZL; Wang X; Yu LY; Zhao LX; Cen S
    Yao Xue Xue Bao; 2011 Apr; 46(4):377-82. PubMed ID: 21751489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylative inactivation of rifampicin by Nocardia otitidiscaviarum.
    Yazawa K; Mikami Y; Maeda A; Morisaki N; Iwasaki S
    J Antimicrob Chemother; 1994 Jun; 33(6):1127-35. PubMed ID: 7928806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.